【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cellulitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Cellulitis 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Cellulitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Durata Therapeutics, Inc. 31
Clinical Trial Overview of Durata Therapeutics, Inc. 31
Ortho- McNeil Janssen Scientific Affairs, LLC 32
Clinical Trial Overview of Ortho- McNeil Janssen Scientific Affairs, LLC 32
Trius Therapeutics, Inc. 33
Clinical Trial Overview of Trius Therapeutics, Inc. 33
Theravance, Inc. 34
Clinical Trial Overview of Theravance, Inc. 34
Affinium Pharmaceuticals, Ltd. 35
Clinical Trial Overview of Affinium Pharmaceuticals, Ltd. 35
Targanta Therapeutics Corporation (Inactive) 36
Clinical Trial Overview of Targanta Therapeutics Corporation (Inactive) 36
The Medicines Company 37
Clinical Trial Overview of The Medicines Company 37
Cubist Pharmaceuticals, Inc. 38
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
Clinical Trial Overview of Top Universities / Institutes / Hospitals 41
Hospital Universitario Evangelico de Curitiba 41
Clinical Trial Overview of Hospital Universitario Evangelico de Curitiba 41
University of Nottingham’s School Of Pharmacy 42
Clinical Trial Overview of University of Nottingham’s School Of Pharmacy 42
The University of Nottingham 43
Clinical Trial Overview of The University of Nottingham 43
William Beaumont Hospitals 44
Clinical Trial Overview of William Beaumont Hospitals 44
Rhode Island Hospital 45
Clinical Trial Overview of Rhode Island Hospital 45
The University of British Columbia 46
Clinical Trial Overview of The University of British Columbia 46
University of Massachusetts 47
Clinical Trial Overview of University of Massachusetts 47
New York University School of Medicine 48
Clinical Trial Overview of New York University School of Medicine 48
Federal University of Sao Paulo 49
Clinical Trial Overview of Federal University of Sao Paulo 49
U.S. Centers for Disease Control and Prevention 50
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 50
Massachusetts General Hospital 51
Clinical Trial Overview of Massachusetts General Hospital 51
University of Arkansas 52
Clinical Trial Overview of University of Arkansas 52
University of Cincinnati 53
Clinical Trial Overview of University of Cincinnati 53
Five Key Clinical Profiles 54
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 113
【レポート販売概要】
■ タイトル:Cellulitis:グローバル臨床試験レビューH1, 2013■ 英文:Cellulitis Global Clinical Trials Review, H1, 2013
■ 発行日:2013年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160572
■ 調査対象地域:グローバル
- ホウ砂の世界市場Borax (CAS 12179-04-3, 1303-96-4) Market Research Report 2014 presents comprehensive data on borax markets globally and regionally (Europe, Asia, North America etc.) The report includes borax description, covers its application areas and related patterns. It overviews borax market, names borax producers and indicates its suppliers. Besides, the report provides borax prices in regional markets. In …
- Beta-2 Microglobulin:医療検査市場2014The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- バイオセラミックスの世界市場分析:材料別(アルミナ、ジルコニア)、用途別(歯科、整形外科)、セグメント予測Global bioceramics market is expected to reach USD 19.05 billion by 2022, according to a new report by Grand View Research, Inc. Rising ageing population coupled with increasing occurrences of osteoarthritis is expected to augment market growth over the next seven years. Growing need to maintain a healthy lifestyle coupled with introduction of new low cost preventive care measures has led to the u …
- Liver Transplantation:グローバル臨床試験レビューH2, 2013Liver Transplantation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Liver Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Transplantation. It includes an overview of the trial numbers and the …
- 世界の電気小型車市場【2015年1月更新版】This latest just-auto report edition offers a global review of the electric vehicles sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Electric vehicles market size estimates Latest technologies and trends Profiles of the major players including their strategies and prospects Market size forecasts You can use this report to: Understand the …
- インスリンポンプの世界市場2016-2020About the Insulin Pumps Market Diabetes is a common metabolic disease in which an individual's blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes, the body does not produce sufficient insulin, and it is usua …
- 世界のビルオートメーション及び制御市場The report, based on the extensive research study of the global building automation and controls market, is aimed at identifying the entire market of the building automation and controls specifically lighting, security & access, HVAC, entertainment, outdoor controls, elevator controls and BMS. The report covers the overall market and sub-segment markets through extensively detailed classifications …
- ベビーフード(乳児食)の世界市場動向2014Summary “Baby Nutrition Insights 2014 - Issue 21” is a new report that is the result of ERC's extensive market research covering the baby food industry. It is a quarterly review of the latest news and analysis for the infant formula and baby food industry. The report covers all the major countries across all geographies and provides latest updates for companies engaged in the baby food market. Key …
- Medline Industries, Inc.:市場シェア分析Medline Industries, Inc. Market Share Analysis Summary GlobalData’s new report, “Medline Industries, Inc. Market Share Analysis” provides in-depth information on Medline Industries, Inc.’s market position in the different medical equipment markets it operates in. The report provides Medline Industries, Inc. market share information in seven key market categories – Disposable Hospital Supplies, Mob …
- 劇場管理システム(TMS)の世界市場2016-2020About Theatre Management Systems A theater management system (TMS) refers to a software program that helps in the management of movie theaters. The software program offers centralized management of theater operations including schedule management, content distribution, playback monitoring, status monitoring, time management, and content management. Technavio’s analysts forecast the global TMS mark …
- Mucopolysaccharidosis III (MPS III) (サンフィリッポ症候群):グローバル臨床試験動向(2014年上半期)Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) clinical trial scenario. This report provides elemental information and data re …
- ヨーロッパ主要国の気道装置・麻酔装置市場EU5 Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "EU5 Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the EU5 Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, Airway M …
- Sonde Resources Corp.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Sonde Resources Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Sonde Resources Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 事業提携・ライセンシング・投資・M&A動向:June 2013(製薬業界)Partnerships, Licensing, Investments and M&A Deals and Trends for June 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for June 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de …
- モバイルコンテンツ管理の世界市場The mobile content management market size is expected to grow from USD 2.00 Billion in 2015 to USD 5.63 Billion in 2020, at a Compound Annual Growth Rate (CAGR) of 23.0%. The mobile content management solutions are gaining traction due to the increased need to access corporate content from portable devices at any time. Most organizations have started treating enterprise content as a vital corporat …